Loading...
Loading...
India's plasma imports from UNITED KINGDOM total $298.2K across 270 shipments from 15 foreign suppliers. TCS BIOSCIENCES LTD leads with $76.5K in import value; the top 5 suppliers together control 81.8% of this origin. Leading Indian buyers include VEEDA CLINICAL RESEARCH LIMITED. This corridor reflects India's pharmaceutical import demand for plasma โ a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.

TCS BIOSCIENCES LTD is the leading Plasma supplier from UNITED KINGDOM to India, with import value of $76.5K across 4 shipments. The top 5 suppliers โ TCS BIOSCIENCES LTD, QUOTIENT SCIENCES, Q2 SOLUTIONS, TCS BIOSCIENCES LIMITED, Q SQUARED SOLUTIONS LIMITED โ collectively account for 81.8% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TCS BIOSCIENCES LTD | $76.5K | 4 | 25.7% |
| 2 |
| QUOTIENT SCIENCES |
| $61.9K |
| 23 |
| 20.8% |
| 3 | Q2 SOLUTIONS | $54.7K | 95 | 18.4% |
| 4 | TCS BIOSCIENCES LIMITED | $36.8K | 1 | 12.3% |
| 5 | Q SQUARED SOLUTIONS LIMITED | $14.1K | 51 | 4.7% |
| 6 | HART BIOLOGICALS LTD | $13.7K | 2 | 4.6% |
| 7 | ABCAM PLC | $9.5K | 18 | 3.2% |
| 8 | ACCORD UK LTD | $5.2K | 1 | 1.7% |
| 9 | M/S. AMERICAN TYPE CULTURE COLLECT | $4.7K | 3 | 1.6% |
| 10 | MEDICINES & HEALTHCARE PRODUCTS REGULATORY AGENCY | $4.3K | 3 | 1.4% |
| 11 | SERADIAG LTD | $4.1K | 2 | 1.4% |
| 12 | ABCAM SINGAPORE PTE LTD., | $2.2K | 8 | 0.7% |
| 13 | INTERVET INTERNATIONAL B V | $2.2K | 1 | 0.7% |
| 14 | ABBALTIS LTD | $2.0K | 19 | 0.7% |
| 15 | NATIONAL INSTITUTE FOR BIOLOGICAL | $1.6K | 2 | 0.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | VEEDA CLINICAL RESEARCH LIMITED | $123.2K | 154 | 41.3% |
| 2 | LOTUS LABS PRIVATE LIMITED | $109.1K | 3 | 36.6% |
| 3 | TULIP DIAGNOSTICS PRIVATE LIMITED | $15.5K | 16 | 5.2% |
| 4 | ALLIED SCIENTIFIC PRODUCTS., | $7.0K | 14 | 2.4% |
| 5 | INTAS PHARMACEUTICALS LIMITED | $5.2K | 1 | 1.7% |
| 6 | WATSON PHARMA PRIVATE LIMITED | $4.8K | 6 | 1.6% |
| 7 | CHROMACHEMIE LABORATORY PRIVATE LIMITED | $4.7K | 3 | 1.6% |
| 8 | YASHRAJ BIOTECHNOLOGY LIMITED | $4.4K | 7 | 1.5% |
| 9 | ADVY CHEMICAL PRIVATE LIMITED | $4.4K | 7 | 1.5% |
| 10 | BHARATI VIDYAPEETH | $4.0K | 2 | 1.3% |
| 11 | NULIFE CONSULTANTS AND DISTRIBUTORS PRIVATE LIMITE | $2.4K | 9 | 0.8% |
| 12 | INTERVET INDIA PRIVATE LIMITED | $2.2K | 1 | 0.7% |
| 13 | VEEDA CLINICAL RESEARCH PVT. LTD. | $1.8K | 6 | 0.6% |
| 14 | VEEDA CLINICAL RESEARCH PVT LTD | $1.6K | 5 | 0.5% |
| 15 | ALLIED SCIENTIFIC PRODUCTS., | $1.6K | 2 | 0.5% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Plasma suppliers from UNITED KINGDOM to India include TCS BIOSCIENCES LTD, QUOTIENT SCIENCES, Q2 SOLUTIONS. The leading supplier is TCS BIOSCIENCES LTD with import value of $76.5K USD across 4 shipments. India imported Plasma worth $298.2K USD from UNITED KINGDOM in total across 270 shipments.
India imported Plasma worth $298.2K USD from UNITED KINGDOM across 270 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Plasma sourced from UNITED KINGDOM include VEEDA CLINICAL RESEARCH LIMITED, LOTUS LABS PRIVATE LIMITED, TULIP DIAGNOSTICS PRIVATE LIMITED. The largest buyer is VEEDA CLINICAL RESEARCH LIMITED with $123.2K in imports across 154 shipments.
The total value of Plasma imports from UNITED KINGDOM to India is $298.2K USD, across 270 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
270 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists